Clinical Lung Cancer

1

Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer

Chu, Michael P., Ghosh, Sunita, Chambers, Carole R., Basappa, Naveen, Butts, Charles A., Chu, Quincy, Fenton, David, Joy, Anil A., Sangha, Randeep, Smylie, Michael, Sawyer, Michael B.

Journal:

Year:

2015

Language:

english

File:

PDF, 255 KB

english, 2015

2

Multimodality Treatment With Surgery for Locally Advanced Non–Small-Cell Lung Cancer With N2 Disease: A Review Article

Toyokawa, Gouji, Takenoyama, Mitsuhiro, Ichinose, Yukito

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 311 KB

english, 2015

3

Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer

Lee, Youngjoo, Lee, Geon Kook, Hwang, Jung-Ah, Yun, Tak, Kim, Heung Tae, Lee, Jin Soo

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 445 KB

english, 2015

4

Long-Term Lung Cancer Survivors Have Permanently Decreased Quality of Life After Surgery

Rauma, Ville, Sintonen, Harri, Räsänen, Jari V., Salo, Jarmo A., Ilonen, Ilkka K.

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 458 KB

english, 2015

5

Outcomes by Tumor Histology and KRAS Mutation Status After Lung Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer

Mak, Raymond H., Hermann, Gretchen, Lewis, John H., Aerts, Hugo J.W.L., Baldini, Elizabeth H., Chen, Aileen B., Colson, Yolonda L., Hacker, Fred H., Kozono, David, Wee, Jon O., Chen, Yu-Hui, Catalano,

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 388 KB

english, 2015

6

Metachronous and Synchronous Primary Lung Cancers: Diagnostic Aspects, Surgical Treatment, and Prognosis

Loukeri, Angeliki A., Kampolis, Christos F., Ntokou, Anna, Tsoukalas, George, Syrigos, Konstantinos

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 264 KB

english, 2015

7

Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial

Tiseo, Marcello, Boni, Luca, Ambrosio, Francesca, Camerini, Andrea, Vitale, Maria Giuseppa, Baldini, Editta, Cinieri, Saverio, Zanelli, Francesca, Defraia, Efisio, Passalacqua, Rodolfo, Crino, Lucio,

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 240 KB

english, 2015

8

Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment

Kuiper, Justine L., Heideman, Danielle A.M., Würdinger, Tom, Grünberg, Katrien, Groen, Harry J.M., Smit, Egbert F.

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 297 KB

english, 2015

9

Chemoprevention and Screening for Lung Cancer: Changing Our Focus to Former Smokers

Clamon, Gerald

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 174 KB

english, 2015

10

A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non–Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial

Fasano, Morena, Della Corte, Carminia Maria, Capuano, Annalisa, Sasso, Ferdinando Carlo, Papaccio, Federica, Berrino, Liberato, Ciardiello, Fortunato, Morgillo, Floriana

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 216 KB

english, 2015

11

Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non–Small-Cell Lung Cancer

Takenaka, Tomoyoshi, Takenoyama, Mitsuhiro, Toyozawa, Ryo, Inamasu, Eiko, Yoshida, Tsukihisa, Toyokawa, Gouji, Shiraishi, Yoshimasa, Hirai, Fumihiko, Yamaguchi, Masafumi, Seto, Takashi, Ichinose, Yuki

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 308 KB

english, 2015

12

Editorial Board

Journal:

Clinical Lung Cancer

Year:

2015

Language:

english

File:

PDF, 66 KB

english, 2015

13

Volume 16; Issue 1

Gastric Acid Suppression Is Associated With Decreased Erlotinib Efficacy in Non–Small-Cell Lung Cancer

Multimodality Treatment With Surgery for Locally Advanced Non–Small-Cell Lung Cancer With N2 Disease: A Review Article

Clinical Likelihood of Sporadic Primary EGFR T790M Mutation in EGFR-Mutant Lung Cancer

Long-Term Lung Cancer Survivors Have Permanently Decreased Quality of Life After Surgery

Outcomes by Tumor Histology and KRAS Mutation Status After Lung Stereotactic Body Radiation Therapy for Early-Stage Non–Small-Cell Lung Cancer

Metachronous and Synchronous Primary Lung Cancers: Diagnostic Aspects, Surgical Treatment, and Prognosis

Italian Multicenter Phase III Randomized Study of Cisplatin–Etoposide With or Without Bevacizumab as First-Line Treatment in Extensive Stage Small Cell Lung Cancer: Treatment Rationale and Protocol Design of the GOIRC-AIFA FARM6PMFJM Trial

Rationale and Study Design of the IRENE-Trial (NVALT-16): A Phase II Trial to Evaluate Iressa Rechallenge in Advanced NSCLC Patients With an Activating EGFR Mutation Who Responded to an EGFR-TKI Used As First-Line or Previous Treatment

Chemoprevention and Screening for Lung Cancer: Changing Our Focus to Former Smokers

A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non–Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial

Concurrent Chemoradiotherapy for Patients With Postoperative Recurrence of Surgically Resected Non–Small-Cell Lung Cancer

Editorial Board

Table of Contents